Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment (Q40174984)
scientific article published on 16 December 2006
Language:
Current Data About Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment
(P31) (Q13442814)
(P248)
(P698) 17276407
(P813) Monday, September 18, 2017

(P304) 990-1000
(P248)
(P698) 17276407
(P813) Monday, September 18, 2017

(P407) (Q1860)

(P433) 7
(P248)
(P698) 17276407
(P813) Monday, September 18, 2017

(P478) 73
(P248)
(P698) 17276407
(P813) Monday, September 18, 2017

(P577) Saturday, December 16, 2006
(P248)
(P698) 17276407
(P813) Monday, September 18, 2017

(P921) (Q189159)
(P887)

(P1433) (Q864229)
(P248)
(P698) 17276407
(P813) Monday, September 18, 2017

(P1476) "Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment" (language: en)
(P248)
(P698) 17276407
(P813) Monday, September 18, 2017

(P2093) Canhua Huang
(P1545) 1
(P248)
(P698) 17276407
(P813) Monday, September 18, 2017

Hiroshi Ida
(P1545) 2
(P248)
(P698) 17276407
(P813) Monday, September 18, 2017

Kosei Ito
(P1545) 3
(P248)
(P698) 17276407
(P813) Monday, September 18, 2017

Haiyuan Zhang
(P1545) 4
(P248)
(P698) 17276407
(P813) Monday, September 18, 2017

Yoshiaki Ito
(P1545) 5
(P248)
(P698) 17276407
(P813) Monday, September 18, 2017

other details
description scientific article published on 16 December 2006

External Links
(P356) 10.1016/J.BCP.2006.12.013
(P698) 17276407